两阶段肝切除术后复发再手术对结直肠癌肝转移患者预后的影响
该研究纳入1992至2012年间93例完成两阶段肝切除术的广泛双叶结直肠癌肝转移患者,评估复发后再手术对长期生存的影响。TSH术后5年总生存率为41.3%,再手术组OS显著优于未再手术组(45.8% vs 26.3%,P=0.0041),多因素分析显示再手术是OS的独立预后因素(HR 0.31,P=0.0012)。
要点
- TSH术后5年OS率为41.3%,复发后再手术与更长OS相关
- 再手术是TSH术后OS的独立预后因素(HR 0.31,P=0.0012)
- 强调强化肿瘤外科随访以把握再手术机会
核心结论
- TSH术后复发再手术可能对广泛双叶CRLM患者的长期生存至关重要。
研究设计与样本
- 回顾性队列研究,1992至2012年间1235例CRLM肝切除患者中139例计划行TSH,93例完成TSH并入组。
主要发现
- TSH术后5年OS率为41.3%。
- 81例实现原发灶、CRLM及合并肝外转移完全切除的患者中,62例(76.5%)复发。
- 38例接受再手术,其中31例获挽救;再手术组OS显著长于未再手术组(45.8% vs 26.3%,P=0.0041)。
- 多因素分析显示再手术是TSH术后OS的独立预后因素(HR 0.31,P=0.0012)。
临床怎么用
- 对完成TSH的广泛双叶CRLM患者应加强肿瘤外科随访,及时评估复发并争取再手术机会。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the impact of repeat surgery for recurrence on the long-term survival after 2-stage hepatectomy (TSH) for extensive colorectal liver metastases (CRLM). BACKGROUND: Although TSH is now deemed effective for selected patients with extensive bilobar CRLM, disease recurrence after TSH is very frequent because of the extensive tumor load. METHODS: Among a total cohort of 1235 patients who underwent hepatectomy for CRLM between 1992 and 2012, 139 with extensive bilobar CRLM were scheduled for TSH. Of these, 93 patients had completion of TSH and were enrolled in this study. RESULTS: The 5-year overall survival (OS) rate after TSH was 41.3%. Twenty-two patients (23.7%) had a concomitant extrahepatic disease (EHD), and curative resection of concomitant EHD was achieved in 13 patients. Among the 81 patients who achieved complete tumor removal for primary, CRLM, and concomitant EHD, 62 (76.5%) had recurrence. Repeat surgery was performed in 38 patients; 35 for recurrence after curative surgery and 3 for liver recurrence with unresected concomitant EHD or primary tumor. Of these 38 patients, 31 were salvaged. The patients who underwent repeat surgery had a significantly longer OS than those who did not (45.8% vs 26.3%; P = 0.0041). A multivariate analysis revealed that repeat surgery was an independent prognostic factor of the OS after TSH (hazard ratio 0.31, P = 0.0012). CONCLUSIONS: Repeat surgery for recurrence after TSH may be crucial for the long-term survival in patients with extensive bilobar CRLM. Intensive oncosurgical surveillance is essential to avoid missing the chance for repeat surgery after TSH.
引用
- Imai K, Benitez CC, Allard MA, et al. Impact of Surgical Treatment for Recurrence After 2-Stage Hepatectomy for Colorectal Liver Metastases, on Patient Outcome. Ann Surg. 2019. PMID: 28820745. doi:10.1097/SLA.0000000000002472
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。